Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
For the first time since 2017, Canadian doctors have released updated clinical guidelines for antiretroviral medications used ...
The Canadian Press on MSN
New HIV prevention guidelines say doctors should not 'gatekeep' meds
“There are many reasons people may not disclose HIV risk behaviours to health care providers, including shame, medical ...
Scientists tested a multi-step immune-based therapy designed to retrain the body to control HIV without continuous antiviral treatment.
Activists urge India to waive clinical trial requirements for lenacapavir, as patent barriers threaten access to the vital ...
By Kisean Joseph [email protected] Ground-breaking advancements in HIV treatment and prevention could ...
South Africa has begun administering lenacapavir, a long-acting HIV prevention drug, to selected individuals as part of a new study led ...
But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health is starting to come into focus. Just days ago, the State Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback